相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SOX2 has dual functions as a regulator in the progression of neuroendocrine prostate cancer
Haiying Li et al.
LABORATORY INVESTIGATION (2020)
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
Ritika Tiwari et al.
NATURE COMMUNICATIONS (2020)
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance
Joshi J. Alumkal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors
Johanna M. Schafer et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4
Daniel J. Coleman et al.
NEOPLASIA (2020)
Lineage plasticity-mediated therapy resistance in prostate cancer
Alexandra M. Blee et al.
ASIAN JOURNAL OF ANDROLOGY (2019)
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome
Nataly Stylianou et al.
ONCOGENE (2019)
Increased Serine and One-Carbon Pathway Metabolism by PKCλ/l Deficiency Promotes Neuroendocrine Prostate Cancer
Miguel Reina-Campos et al.
CANCER CELL (2019)
ProSTAR: A phase lb/II study of CPI-1205, a small molecule inhibitor of EZH2, combined with enzalutamide (E) or abiraterone/prednisone (A/P) in patients with metastatic castration-resistant prostate cancer (mCRPC).
Mary-Ellen Taplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
Loredana Puca et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
CUL4B promotes prostate cancer progression by forming positive feedback loop with SOX4
Mei Qi et al.
ONCOGENESIS (2019)
Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
Wei Lu et al.
DEVELOPMENTAL CELL (2019)
Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer
Vipul Bhatia et al.
TRENDS IN MOLECULAR MEDICINE (2019)
E-cadherin is required for metastasis in multiple models of breast cancer
Veena Padmanaban et al.
NATURE (2019)
Neuroendocrine Differentiation of Prostate Cancer-An Intriguing Example of Tumor Evolution at Play
Girijesh Kumar Patel et al.
CANCERS (2019)
The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
Chin-Yap Loh et al.
CELLS (2019)
Developmental Plasticity and Cellular Reprogramming in Caenorhabditis elegans
Joel Rothman et al.
GENETICS (2019)
Epithelial-mesenchymal Transition and Cancer Stem Cells: At the Crossroads of Differentiation and Dedifferentiation
Hanmin Wang et al.
DEVELOPMENTAL DYNAMICS (2019)
ONECUT2 is a driver of neuroendocrine prostate cancer
Haiyang Guo et al.
NATURE COMMUNICATIONS (2019)
Prostate Stem Cells and Cancer Stem Cells
Jia J. Li et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Controversies around epithelial-mesenchymal plasticity in cancer metastasis
Elizabeth D. Williams et al.
NATURE REVIEWS CANCER (2019)
The Tumor Immune Contexture of Prostate Cancer
Natasha Vitkin et al.
FRONTIERS IN IMMUNOLOGY (2019)
Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-beta signaling
Yuhu Dai et al.
THERANOSTICS (2019)
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2019)
Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497)
Pei-Pei Kung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines
Octavio Orellana-Serradell et al.
ASIAN JOURNAL OF ANDROLOGY (2018)
Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2
Yuan-Chin Tsai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
EMT, stemness and tumor plasticity in aggressive-variant neuroendocrine prostate cancers
Rama Soundararajan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Alastair H. Davies et al.
NATURE REVIEWS UROLOGY (2018)
Intratumor heterogeneity in prostate cancer
Shalini S. Yadav et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics
Vittoria Poli et al.
STEM CELLS INTERNATIONAL (2018)
Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer
Stephen Yiu Chuen Choi et al.
CANCER MEDICINE (2018)
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming
Rajeev Mishra et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
CRLX101 plus olaparib in patients with metastatic castration-resistant prostate cancer.
Gang Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance
Fei Chen et al.
NATURE COMMUNICATIONS (2018)
CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α
Xi Tian et al.
CANCER RESEARCH (2017)
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Jennifer L. Bishop et al.
CANCER DISCOVERY (2017)
Clinical significance of epithelial-mesenchymal transition markers in prostate cancer
Sandy Figiel et al.
HUMAN PATHOLOGY (2017)
Cell plasticity in epithelial homeostasis and tumorigenesis
Julia Varga et al.
NATURE CELL BIOLOGY (2017)
Targeting Developmental Pathways: The Achilles Heel of Cancer?
Wolfram C. M. Dempke et al.
ONCOLOGY (2017)
Epigenetic plasticity and the hallmarks of cancer
William A. Flavahan et al.
SCIENCE (2017)
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
Ping Mu et al.
SCIENCE (2017)
Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
Min Zou et al.
CANCER DISCOVERY (2017)
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance
Mannan Nouri et al.
Oncotarget (2017)
Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial-Mesenchymal Plasticity in Prostate Cancer
Lu Miao et al.
CANCER RESEARCH (2017)
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
Wenchu Wang et al.
CHINESE JOURNAL OF CANCER (2017)
Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis
Begum Erdogan et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers
Ana M. Aparicio et al.
CLINICAL CANCER RESEARCH (2016)
Transforming growth factor β as regulator of cancer stemness and metastasis
Claudia Bellomo et al.
BRITISH JOURNAL OF CANCER (2016)
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
Etienne Dardenne et al.
CANCER CELL (2016)
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
John K. Lee et al.
CANCER CELL (2016)
Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors
Saoirse O. Dolly et al.
CLINICAL CANCER RESEARCH (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Hypoxia inducible factor-1α-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells
Mingchuan Li et al.
ONCOLOGY REPORTS (2016)
REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling
Tzu-Ping Lin et al.
ONCOTARGET (2016)
A phase I, open-label study of GSK2816126, an enhancer of zeste homolog 2 (EZH2) inhibitor, in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (tFL), other non-Hodgkin's lymphomas (NHL), multiple myeloma (MM) and solid tumor.
Timothy Anthony Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells
Ma Zhifang et al.
BMC BIOCHEMISTRY (2015)
The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
Pierrick G. J. Fournier et al.
CANCER CELL (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Vicki Plaks et al.
CELL STEM CELL (2015)
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
Nelma Pertega-Gomes et al.
JOURNAL OF PATHOLOGY (2015)
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Paul C. Boutros et al.
NATURE GENETICS (2015)
PROSTATE CANCER Intrapatient heterogeneity in prostate cancer
Himisha Beltran et al.
NATURE REVIEWS UROLOGY (2015)
Advanced neuroendocrine prostate tumors regress to stemness
Leigh Ellis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation
Valentina Doldi et al.
ONCOTARGET (2015)
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
Shusuke Akamatsu et al.
CELL REPORTS (2015)
Polycomb-mediated silencing in neuroendocrine prostate cancer
Pier-Luc Clermont et al.
CLINICAL EPIGENETICS (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
TMPRSS2: ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation
Z. Mounir et al.
ONCOGENE (2015)
Androgen receptor signaling in prostate cancer
Zoran Culig et al.
CANCER AND METASTASIS REVIEWS (2014)
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Dong Lin et al.
CANCER RESEARCH (2014)
Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures
Wouter R. Karthaus et al.
CELL (2014)
Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells
Dong Ren et al.
CELL AND TISSUE RESEARCH (2014)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer
Masaki Shiota et al.
CLINICAL CANCER RESEARCH (2014)
Dedifferentiation and reprogramming: origins of cancer stem cells
Dinorah Friedmann-Morvinski et al.
EMBO REPORTS (2014)
Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer
Sheeba Jacob et al.
ENDOCRINE-RELATED CANCER (2014)
Zeb1 promotes androgen independence of prostate cancer via induction of stem cell-like properties
Ping Li et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
Charlotte Svensson et al.
NUCLEIC ACIDS RESEARCH (2014)
Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer
David Brocks et al.
CELL REPORTS (2014)
Luminal Cells Are Favored as the Cell of Origin for Prostate Cancer
Zhu A. Wang et al.
CELL REPORTS (2014)
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Vivek K. Arora et al.
CELL (2013)
SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells
Adrian P. Rybak et al.
CELLULAR SIGNALLING (2013)
Cell Plasticity and Heterogeneity in Cancer
Nemanja D. Marjanovic et al.
CLINICAL CHEMISTRY (2013)
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
Kouji Izumi et al.
EMBO MOLECULAR MEDICINE (2013)
Epithelial-mesenchymal plasticity in carcinoma metastasis
Jeff H. Tsai et al.
GENES & DEVELOPMENT (2013)
A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer
Gary Hudes et al.
INVESTIGATIONAL NEW DRUGS (2013)
Patient-derived tissue slice grafts accurately depict response of high-risk primary prostate cancer to androgen deprivation therapy
Hongjuan Zhao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
M. Angela Nieto
SCIENCE (2013)
Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
T-H Lin et al.
CELL DEATH & DISEASE (2013)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Nicola J. Clegg et al.
CANCER RESEARCH (2012)
The PSA-/Io Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration
Jichao Qin et al.
CELL STEM CELL (2012)
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
Toni Celia-Terrassa et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
Anna V. Lapuk et al.
JOURNAL OF PATHOLOGY (2012)
Androgen receptor coregulators: Recruitment via the coactivator binding groove
Dennis J. van de Wijngaart et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Targeting Androgen Receptor to Suppress Macrophage-induced EMT and Benign Prostatic Hyperplasia (BPH) Development
Tianjing Lu et al.
MOLECULAR ENDOCRINOLOGY (2012)
Slug, a Unique Androgen-Regulated Transcription Factor, Coordinates Androgen Receptor to Facilitate Castration Resistance in Prostate Cancer
Kaijie Wu et al.
MOLECULAR ENDOCRINOLOGY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
The complexity of prostate cancer: genomic alterations and heterogeneity
Lara K. Boyd et al.
NATURE REVIEWS UROLOGY (2012)
Epcam, CD44, and CD49f Distinguish Sphere-Forming Human Prostate Basal Cells from a Subpopulation with Predominant Tubule Initiation Capability
Changyong Guo et al.
PLOS ONE (2012)
Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status
Renea A. Taylor et al.
STEM CELLS (2012)
Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells
Petrina Barnett et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells
Adrian P. Rybak et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate
Charles C. Guo et al.
HUMAN PATHOLOGY (2011)
Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
Jones T. Nauseef et al.
NATURE REVIEWS UROLOGY (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Revisiting the concept of cancer stem cells in prostate cancer
Z. A. Wang et al.
ONCOGENE (2011)
Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations
S. Floor et al.
ONCOGENE (2011)
Macrophages Induce Neuroendocrine Differentiation of Prostate Cancer Cells Via BMP6-IL6 Loop
Geun Taek Lee et al.
PROSTATE (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
Lycopene Enhances Docetaxel's Effect in Castration-Resistant Prostate Cancer Associated with Insulin-like Growth Factor I Receptor Levels
Yaxiong Tang et al.
NEOPLASIA (2011)
Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
Tina Bianco-Miotto et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Reciprocal Activation of Prostate Cancer Cells and Cancer-Associated Fibroblasts Stimulates Epithelial-Mesenchymal Transition and Cancer Stemness
Elisa Giannoni et al.
CANCER RESEARCH (2010)
F-18 FDG PET/CT Imaging in Small Cell Prostate Cancer
Rodrigo de Carvalho Flamini et al.
CLINICAL NUCLEAR MEDICINE (2010)
N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer
Karin Jennbacken et al.
ENDOCRINE-RELATED CANCER (2010)
Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
Meng-Lei Zhu et al.
FASEB JOURNAL (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Nallasivam Palanisamy et al.
NATURE MEDICINE (2010)
Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
Dejuan Kong et al.
PLOS ONE (2010)
Human Prostate Sphere-Forming Cells Represent a Subset of Basal Epithelial Cells Capable of Glandular Regeneration In Vivo
Isla P. Garraway et al.
PROSTATE (2010)
Snail Transcription Factor Regulates Neuroendocrine Differentiation in LNCaP Prostate Cancer Cells
Danielle McKeithen et al.
PROSTATE (2010)
Identification of a Cell of Origin for Human Prostate Cancer
Andrew S. Goldstein et al.
SCIENCE (2010)
Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1
Ira Kogan-Sakin et al.
CARCINOGENESIS (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Nuclear Factor-KB-Mediated Transforming Growth Factor-β-Induced Expression of Vimentin Is an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy
Qiang Zhang et al.
CLINICAL CANCER RESEARCH (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Ulrich Wellner et al.
NATURE CELL BIOLOGY (2009)
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Wennuan Liu et al.
NATURE MEDICINE (2009)
Selective Expression of CD44, a Putative Prostate Cancer Stem Cell Marker, in Neuroendocrine Tumor Cells of Human Prostate Cancer
Ganesh S. Palapattu et al.
PROSTATE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
The role of SPINK1 in ETS rearrangement-negative prostate cancers
Scott A. Tomlins et al.
CANCER CELL (2008)
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways
Tamer T. Onder et al.
CANCER RESEARCH (2008)
Insulin-like growth factor-l-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells
Tisheeka R. Graham et al.
CANCER RESEARCH (2008)
SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion
Hongyun Wang et al.
CANCER RESEARCH (2008)
Epithelial-Mesenchymal Transition Induced by Growth Suppressor p12CDK2-AP1 Promotes Tumor Cell Local Invasion but Suppresses Distant Colony Growth
Takanori Tsuji et al.
CANCER RESEARCH (2008)
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Sooryanarayana Varambally et al.
SCIENCE (2008)
Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic
Mingfang Ao et al.
CANCER RESEARCH (2007)
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin
C. C. Yates et al.
BRITISH JOURNAL OF CANCER (2007)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells
L Patrawala et al.
ONCOGENE (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells
WJ Huss et al.
CANCER RESEARCH (2005)
Global histone modification patterns predict risk of prostate cancer recurrence
DB Seligson et al.
NATURE (2005)
TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia
NA Bhowmick et al.
SCIENCE (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Molecular biology of the androgen receptor
EP Gelmann
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
